PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 14080804

BETA-ETHYLMALATE SYNTHETASE.

R RABIN·H C REEVES·S J AJL
View original source ↗Export metadata ↓

Abstract

Rabin, Robert (Albert Einstein Medical Center, Philadelphia, Pa.), Henry C. Reeves, and Samuel J. Ajl. beta-Ethylmalate synthetase. J. Bacteriol. 86:937-944. 1963.-Pseudomonas aeruginosa, when grown in an inorganic salts medium with butyrate as the sole carbon source, produced an enzyme which catalyzed the condensation of butyryl coenzyme A (CoA) and glyoxylate to form beta-ethylmalic acid. Maximal activity was found in the 40 to 60% (NH(4))(2)SO(4) fraction of cell-free extracts. Mg(++) was stimulatory, and the optimal pH was 8.0 to 8.5. beta-Ethylmalic acid-C(14) was demonstrable in paper chromatograms when either glyoxylate-1-C(14) or butyryl CoA-3-C(14) was included in complete systems incubated anaerobically. When either glyoxylate, butyryl CoA, or enzyme was omitted, beta-ethylmalate was not detected. Further evidence that beta-ethylmalic acid-C(14) was the product of the condensation of butyryl CoA-3-C(14) and nonlabeled glyoxylate was provided by synthesis of the derivative 5-ethyluracil-C(14). The derivative was recrystallized to constant specific activity and identified by its melting point and spectral properties.

Explore related subjects

Acyl Coenzyme AGlyoxylatesLigasesMalatesMetabolismPseudomonas aeruginosaResearchEXPERIMENTAL LAB STUDYLIGASESMALATESMETABOLISMPSEUDOMONAS AERUGINOSAJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R RABIN, H C REEVES, S J AJL. 1963. BETA-ETHYLMALATE SYNTHETASE.. https://doi.org/10.1128/jb.86.5.937-944.1963

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Complexation of fatty acids and fatty acid-CoAs with synthetic O-methylated polysaccharides.

An experimentally simple, but highly reproducible and reliable method has been developed to follow the complexation event of fatty acid (FA) and FA-CoA with polysaccharides. This method was based on the recent discovery of the unique blue-shifted UV absorption associated with the aggregation of tetraenoic fatty acids (TE-FAs) in aqueous solution. Complexation was monitored by recording the intensity of UV absorption at 250 nm ([free TE-FA]) and 303 nm ([complexed TE-FA]), and the K aggregate of C(20) t,t,t,t-TE-FA exhibited the ideal property for this purpose. Synthetic 3-O-methyl-D-mannose- and 6-O-methyl-D-glucose-containing lipopolysaccharides were found to exhibit a broad range of the binding affinities with C(20) t,t,t,t-TE-FAs as well as saturated FAs/FA-CoAs.

Acyl Coenzyme A↗
PubMed2007

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.

Multiple sclerosis (MS) is the most common chronic demyelinating disease of the central nervous system (CNS) and the major cause of neurological disability in young adults in Western countries. In spite of intensive research efforts, treatment options established to date do not sufficiently prevent the accumulation of tissue damage and clinical disability in patients with MS. We here describe recently identified molecules responsible for the inflammatory and the neurodegenerative processes in MS and its animal model, experimental autoimmune encephalomyelitis (EAE), and review new treatment options targeting both aspects of this disease.

Acyl Coenzyme A↗
PubMed2007

High resolution crystal structures of unliganded and liganded human liver ACBP reveal a new mode of binding for the acyl-CoA ligand.

The acyl-CoA binding protein (ACBP) is essential for the fatty acid metabolism, membrane structure, membrane fusion, and ceramide synthesis. Here high resolution crystal structures of human cytosolic liver ACBP, unliganded and liganded with a physiological ligand, myristoyl-CoA are described. The binding of the acyl-CoA molecule induces only few structural differences near the binding pocket. The crystal form of the liganded ACBP, which has two ACBP molecules in the asymmetric unit, shows that in human ACBP the same acyl-CoA binding pocket is present as previously described for the bovine and Plasmodium falciparum ACBP and the mode of binding of the 3'-phosphate-AMP moiety is conserved. Unexpectedly, in one of the acyl-CoA binding pockets the acyl moiety is bound in a reversed mode as compared with the bovine and P. falciparum structures. In this binding mode, the myristoyl-CoA molecule is fully ordered and bound across the two ACBP molecules of the crystallographic asymmetric unit: the 3'-phosphate-AMP moiety is bound in the binding pocket of one ACBP molecule and the acyl chain is bound in the pocket of the other ACBP molecule. The remaining binding pocket cavities of these two ACBP molecules are filled by other ligand fragments. This novel binding mode shows that the acyl moiety can flip out of its classical binding pocket and bind elsewhere, suggesting a mechanism for the acyl-CoA transfer between ACBP and the active site of a target enzyme. This mechanism is of possible relevance for the in vivo function of ACBP.

Acyl Coenzyme A↗